Advanced search
Publication Cover
Artificial Cells, Nanomedicine, and Biotechnology
An International Journal
Volume 46, 2018 - Issue 5
Submit an article Journal homepage
1,038
Views
29
CrossRef citations to date
0
Altmetric
Research-article

MicroRNA-613 inhibits the progression of gastric cancer by targeting CDK9

Yebin LuDepartment of General Surgery, Xiangya Hospital, Central South University, Changsha, China;
,
Ling TangDepartment of Pharmacy, Xiangya Hospital, Central South University, Changsha, China
,
Qi ZhangDepartment of General Surgery, Xiangya Hospital, Central South University, Changsha, China;
,
Zhipeng ZhangDepartment of General Surgery, Xiangya Hospital, Central South University, Changsha, China;
&
Wei WeiDepartment of General Surgery, Xiangya Hospital, Central South University, Changsha, China; Correspondence[email protected]
Pages 980-984 | Received 04 May 2017, Accepted 04 Jul 2017, Published online: 13 Jul 2017

Citations (29)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Cuiping Liu, Yizhou Jiang & Baosan Han. (2020) miR-613 Suppresses Chemoresistance and Stemness in Triple-Negative Breast Cancer by Targeting FAM83A. Cancer Management and Research 12, pages 12623-12633.
Read now
Linsong Mu, Wentao Yu, Hailong Su, Yang Lin, Wu Sui, Xiang Yu & Chengkun Qin. (2019) Relationship between the expressions of PD-L1 and tumour-associated fibroblasts in gastric cancer. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 1036-1042.
Read now
Yichao Mo, Longguang He, Zeru Lai, Zhiheng Wan, Qinshou Chen, Sibo Pan, Liangfu Li, Dasheng Li, Junwei Huang, Fan Xue & Siyao Che. (2019) Gold nano-particles (AuNPs) carrying miR-326 targets PDK1/AKT/c-myc axis in hepatocellular carcinoma. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 2830-2837.
Read now

Articles from other publishers (26)

Jitendra Gupta, Abdulrahman T. Ahmed, Nahla A. Tayyib, Rahman S. Zabibah, Qakhramon Shomurodov, Mostafai N. Kadheim, Fahad Alsaikhan, Pushpamala Ramaiah, Lathamangeswari Chinnasamy & Saeed Samarghandian. (2023) A state-of-art of underlying molecular mechanisms and pharmacological interventions/nanotherapeutics for cisplatin resistance in gastric cancer. Biomedicine & Pharmacotherapy 166, pages 115337.
Crossref
Zhe Zhang, Xiaoyi Zhang, Zhaojun Ren, Xiaoliu Wu, Haishi Qiao, Xin Huang, Wei Zhao, Yuanying Zhang & Kexin Lou. (2023) Biomimetic black phosphorus nanosheets codeliver CDK9 and BRD4 inhibitors for gastric cancer targeted therapy. Journal of Materials Chemistry B 11:26, pages 6131-6140.
Crossref
Qi Jia, Zhiqiang Hu, Nannan Song & Weike Mao. (2022) Flavopiridol Mitigates the Progression of Monocrotaline-Induced Pulmonary Hypertension in Rats by Targeting Cyclin-Dependent Kinase 9. Cardiovascular Drugs and Therapy 37:3, pages 449-460.
Crossref
Aadil Javed, Mahdieh Yarmohammadi, Kemal Sami Korkmaz & Teresa Rubio-Tomás. (2023) The Regulation of Cyclins and Cyclin-Dependent Kinases in the Development of Gastric Cancer. International Journal of Molecular Sciences 24:3, pages 2848.
Crossref
Dipanjan Karati, Kaka Saheb Ramoo Mahadik, Piyush Trivedi & Dileep Kumar. (2023) Molecular Insights on Selective and Specific Inhibitors of Cyclin Dependent Kinase 9 Enzyme (CDK9) for the Purpose of Cancer Therapy. Anti-Cancer Agents in Medicinal Chemistry 23:4, pages 383-403.
Crossref
Yujing Wang, Dehui Ai & Shaoxiong Li. (2022) CirRNA circFAM126A Exerts Oncogenic Functions in NSCLC to Upregulate IRS2. Biochemical Genetics 60:6, pages 2364-2382.
Crossref
Sisi Liu, Yaxin Li, Xilin Wei, Ran Zhang, Yifan Zhang & Chunyan Guo. (2022) Computational Investigations of Coumarin Derivatives as Cyclindependent Kinase 9 Inhibitors Using 3D-QSAR, Molecular Docking and Molecular Dynamics Simulation. Current Computer-Aided Drug Design 18:5, pages 363-380.
Crossref
Rui-Jie Ma, Chao Ma, Kang Hu, Meng-Meng Zhao, Nan Zhang & Zhi-Gang Sun. (2022) Molecular mechanism, regulation, and therapeutic targeting of the STAT3 signaling pathway in esophageal cancer (Review). International Journal of Oncology 61:3.
Crossref
Haifeng Ying, Yinchun Jin, Yuanbiao Guo, Qiong Li, Ming Ruan, Wenhua Zhu, Chen Yang, Qinyu Li & Lan Zheng. (2022) Long non-coding RNA NUT family member 2A-antisense RNA 1 sponges microRNA-613 to increase the resistance of gastric cancer cells to matrine through regulating oxidative stress and vascular endothelial growth factor A. Aging 14:12, pages 5153-5162.
Crossref
Kai Funke, Robert Düster, Prince De-Graft Wilson, Lena Arévalo, Matthias Geyer & Hubert Schorle. (2022) Transcriptional CDK Inhibitors as Potential Treatment Option for Testicular Germ Cell Tumors. Cancers 14:7, pages 1690.
Crossref
Tao Guo, De-Feng Liu & Shi-Hao Peng. (2022) CDK9 is up-regulated and associated with prognosis in patients with papillary thyroid carcinoma. Medicine 101:5, pages e28309.
Crossref
Ishrat Mahjabeen, Yusra Maqsood, Ramsha Abbasi, Malik Waqar Ahmed & Mahmood Akhtar Kayani. (2021) Polymorphism in miRNA target sites of CEP-63 and CEP-152 ring complex influences expression of CEP genes and favors tumorigenesis in glioma . Future Oncology 17:25, pages 3355-3372.
Crossref
Zainab A. Bazzi & Isabella T. Tai. (2021) CDK10 in Gastrointestinal Cancers: Dual Roles as a Tumor Suppressor and Oncogene. Frontiers in Oncology 11.
Crossref
Qingfeng Ni, Yan Zhang, Ran Tao, Xiaolong Li & Jianwei Zhu. (2021) MicroRNA-95-3p serves as a contributor to cisplatin resistance in human gastric cancer cells by targeting EMP1/PI3K/AKT signaling. Aging 13:6, pages 8665-8687.
Crossref
Zeeshan Javed, Khushbukhat Khan, Amna Rasheed, Haleema Sadia, Shahid Raza, Bahare Salehi, William C. Cho, Javad Sharifi-Rad, Wojciech Koch, Wirginia Kukula-Koch, Anna Głowniak-Lipa & Paweł Helon. (2021) MicroRNAs and Natural Compounds Mediated Regulation of TGF Signaling in Prostate Cancer. Frontiers in Pharmacology 11.
Crossref
Fucun Song, Yang Yang & Jixiang Liu. (2021) Long non‑coding RNA MIAT promotes the proliferation and invasion of laryngeal squamous cell carcinoma cells by sponging microRNA‑613. Experimental and Therapeutic Medicine 21:3.
Crossref
Tizhi Wu, Zhen Qin, Yucheng Tian, Jubo Wang, Chenxi Xu, Zhiyu Li & Jinlei Bian. (2020) Recent Developments in the Biology and Medicinal Chemistry of CDK9 Inhibitors: An Update. Journal of Medicinal Chemistry 63:22, pages 13228-13257.
Crossref
Weiran Dai, Xiaoying Chao, Shanshan Li, Shuang Zhou, Guoqiang Zhong & Zhiyuan Jiang. (2020) Long Noncoding RNA HOTAIR Functions as a Competitive Endogenous RNA to Regulate Connexin43 Remodeling in Atrial Fibrillation by Sponging MicroRNA-613. Cardiovascular Therapeutics 2020, pages 1-11.
Crossref
Milad Ashrafizadeh, Ali Zarrabi, Maryam Hashemipour, Massoud Vosough, Masoud Najafi, Md Shahinozzaman, Kiavash Hushmandi, Haroon Khan & Hamed Mirzaei. (2020) Sensing the scent of death: Modulation of microRNAs by Curcumin in gastrointestinal cancers. Pharmacological Research 160, pages 105199.
Crossref
Soudeh Ghafouri-Fard, Reza Vafaee, Hamed Shoorei & Mohammad Taheri. (2020) MicroRNAs in gastric cancer: Biomarkers and therapeutic targets. Gene 757, pages 144937.
Crossref
Jie Mei, Rui Xu, Leiyu Hao & Yan Zhang. (2020) MicroRNA-613: A novel tumor suppressor in human cancers. Biomedicine & Pharmacotherapy 123, pages 109799.
Crossref
Haipeng Liu, Kang Chen, Li Wang, Xiangting Zeng, Zeping Huang, Mei Li, Peng Dong & Xiao Chen. (2019) miR-613 inhibits Warburg effect in gastric cancer by targeting PFKFB2. Biochemical and Biophysical Research Communications 515:1, pages 37-43.
Crossref
Xin Rui, Li Wang, Huafeng Pan, Tingting Gu, Siliang Shao & Jiangyong Leng. (2018) Lnc RNA GAS 6‐ AS 2 promotes bladder cancer proliferation and metastasis via GAS 6‐ AS 2/miR‐298/ CDK 9 axis . Journal of Cellular and Molecular Medicine 23:2, pages 865-876.
Crossref
Hangzhan Ma, Nicole A. Seebacher, Francis J. Hornicek & Zhenfeng Duan. (2019) Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in osteosarcoma. EBioMedicine 39, pages 182-193.
Crossref
Linlin Zhang & Shuangquan Yu. (2018) Role of miR‑520b in non‑small cell lung cancer. Experimental and Therapeutic Medicine.
Crossref
Nicoletta Bianchi, Simone Beninati & Carlo M. Bergamini. (2018) Spotlight on the transglutaminase 2 gene: a focus on genomic and transcriptional aspects. Biochemical Journal 475:9, pages 1643-1667.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.